TranS1
, Nasdaq: TSONDevelops and sells minimally invasive devices to treat lower back disc disease.
Industry: Health Care
First Day Return: +60.0%
TSON
Develops and sells minimally invasive devices to treat lower back disc disease.
| IPO Date | 10/16/2007 |
|---|---|
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $83 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| IPO Intelligence Only |
| Headquarters | Wilmington, NC, United States |
|---|---|
| Founded | 2000 |
| Employees at IPO | n/a |
| Website www.trans1.com | |
TranS1 (TSON) Performance
